Mesoblast Limited
MESO
$10.60
-$1.01-8.66%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -47.31% | -47.31% | -26.41% | 25.51% | 33.56% |
| Total Depreciation and Amortization | -14.82% | -14.82% | 19.90% | -43.86% | 12.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 213.73% | 213.73% | 209.80% | 45.86% | -32.07% |
| Change in Net Operating Assets | 91.58% | 91.58% | 6,353.13% | 113.66% | -345.34% |
| Cash from Operations | 22.27% | 22.27% | 32.77% | 66.33% | 19.25% |
| Capital Expenditure | 45.36% | 45.36% | -4.05% | 51.88% | -185.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 591.51% | 591.51% | -35.85% | -74.63% | -- |
| Cash from Investing | 812.50% | 812.50% | -128.13% | -108.33% | -29.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -66.85% | -66.85% | -557.63% | -317.05% | -144.31% |
| Issuance of Common Stock | -96.62% | -96.62% | -70.51% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.02% | 66.02% | 28.20% | 23.76% | -89.54% |
| Cash from Financing | -113.49% | -113.49% | -88.84% | 185.12% | 885.29% |
| Foreign Exchange rate Adjustments | -149.31% | -149.31% | -2,914.58% | -503.13% | 5.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -499.79% | -499.79% | -132.40% | 80.61% | 117.44% |
